Related Experiment Video
Updated: Apr 4, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Human Tissue Kallikrein Activity in Angiographically Documented Chronic Stable Coronary Artery Disease
Estêvão Lanna Figueiredo1, Carolina Antunes Magalhães2, Karlyse Claudino Belli3
1Departamento de Cardiologia, Hospital Lifecenter, Belo Horizonte, MG, Brazil.
Insights
Coronary artery disease (CAD) patients exhibit reduced urinary human tissue kallikrein (hK1) amidase activity, indicating potential impairment in the renal kallikrein-kinin system (KKS). This finding suggests a link between hK1 levels and cardiovascular health.
Area of Science:
- Biochemistry
- Cardiovascular Medicine
- Nephrology
Background:
- Human tissue kallikrein (hK1) is a crucial enzyme in the kallikrein-kinin system (KKS).
- Reduced urinary hK1 amidase activity is observed in patients with hypertension and heart failure (HF).
- The role of hK1 in coronary artery disease (CAD) pathophysiology is not well understood.
Purpose of the Study:
- To investigate and quantify urinary hK1-specific amidase activity in patients with and without CAD.
- To explore the association between hK1 activity and the presence and severity of coronary artery disease.
Main Methods:
- Sixty-five patients undergoing cardiac catheterism were enrolled.
- Urine samples were collected pre-catheterization and categorized based on coronary lesion presence (CAD vs. non-CAD).
- Urinary hK1 amidase activity was measured using a chromogenic substrate and normalized to creatinine levels.
Main Results:
- Urinary hK1-specific amidase activity was comparable between CAD and non-CAD groups.
- Activity levels in CAD patients were similar to those previously reported for hypertensive and HF patients.
- Neither CAD severity nor hypertension significantly influenced urinary hK1 amidase activity.
Conclusions:
- Patients with CAD demonstrate diminished urinary hK1-specific amidase activity.
- This suggests a potential reduction in renal KKS activity associated with coronary artery disease.
Background:
Human tissue kallikrein (hK1) is a key enzyme in the kallikrein-kinin system (KKS). hK1-specific amidase activity is reduced in urine samples from hypertensive and heart failure (HF) patients. The pathophysiologic role of hK1 in coronary artery disease (CAD) remains unclear.
Objective:
To evaluate hK1-specific amidase activity in the urine of CAD patientsMethods:Sixty-five individuals (18-75 years) who underwent cardiac catheterism (CATH) were included. Random midstream urine samples were collected immediately before CATH. Patients were classified in two groups according to the presence of coronary lesions: CAD (43 patients) and non-CAD (22 patients). hK1 amidase activity was estimated using the chromogenic substrate D-Val-Leu-Arg-Nan. Creatinine was determined using Jaffé's method. Urinary hK1-specific amidase activity was expressed as µM/(min · mg creatinine) to correct for differences in urine flow rates.
Results:
Urinary hK1-specific amidase activity levels were similar between CAD [0.146 µM/(min ·mg creatinine)] and non-CAD [0.189 µM/(min . mg creatinine)] patients (p = 0.803) and remained similar to values previously reported for hypertensive patients [0.210 µM/(min . mg creatinine)] and HF patients [0.104 µM/(min . mg creatinine)]. CAD severity and hypertension were not observed to significantly affect urinary hK1-specific amidase activity.
Conclusion:
CAD patients had low levels of urinary hK1-specific amidase activity, suggesting that renal KKS activity may be reduced in patients with this disease.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies

